Ubicept is a technology company.
Ubicept has raised $8.0M across 1 funding round.
Ubicept has raised $8.0M in total across 1 funding round.
Ubicept has raised $8.0M in total across 1 funding round.
Ubicept's investors include Crosslink Capital, E14 Fund, Gaingels, Northpond Ventures, Ubiquity Ventures, Virta Ventures, WestWave Capital, Balaji Srinivasan, Liu Jiang.
Ubicept is a computational imaging startup that develops advanced image sensors and computer vision algorithms using single-photon perception technology, primarily Single-Photon Avalanche Diode (SPAD) sensors paired with proprietary processing.[1][2][3][4] It builds products like the Ubicept Toolkit for real-time processing and integrations (SPAD and CMOS), enabling machines to perceive clearly in challenging conditions such as fast motion, low light (0.01 lux to sunlight), high dynamic range (150 dB+), and low latency (up to 100k fps effective framerate).[1][2][4] Serving industries including mobility (e.g., autonomous vehicles), manufacturing, surveillance, and robotics, Ubicept solves core problems in computer vision like motion blur, poor lighting, and the limitations of human-centric cameras, delivering crisp imaging without cooling, with scalable CMOS-like manufacturing, and reduced calibration needs.[1][2][4] The company shows strong growth momentum, with the Ubicept Toolkit launching recently (as of mid-2025), CES 2025 demos, and expansions in blog content on HDR and nighttime driving.[2][4]
Ubicept was founded in 2021 by leading scientists from MIT and UW-Madison, including CEO and Co-Founder Sebastian Bauer, Ph.D., and CTO and Co-Founder Tristan Swedish, Ph.D., with founding advisors Andreas Velten, Ph.D., Mohit Gupta, Ph.D., and Ramesh Raskar, Ph.D.[3][4] The idea emerged from groundbreaking research in single-photon imaging at the limits of physics, addressing how conventional cameras fail in motion and variable lighting for machine vision tasks like optical flow, character recognition, and quality control.[1][3][5] Early traction built on this academic foundation, evolving into a spinoff with operations in Boston, MA, and Sun Prairie, WI (near Madison), and real-world demos by 2025, including CES unveilings of photon-level processing for AI-driven applications.[2][3][4][5]
Ubicept rides the wave of AI-powered computer vision in real-world autonomy and robotics, where legacy cameras—optimized for human eyes—fail in edge cases like dark navigation or variable lighting, limiting progress in the "next big AI wave."[4] Timing is ideal amid booming demand for robust perception in autonomous vehicles, drones, and industrial automation, fueled by SPAD advancements and the shift to machine-optimized sensors.[1][2][4][5] Market forces like scaling CMOS production and software integration favor Ubicept, enabling it to "superpower" ecosystems by bridging physics-limited research to practical tools, influencing standards for low-light, high-speed imaging in mobility, manufacturing, and surveillance.[2][3][4]
Ubicept is poised to dominate single-photon computer vision with its Toolkit scaling across industries, potentially powering next-gen autonomy as AI demands flawless perception in motion-heavy environments.[2][4] Trends like edge AI processing, SPAD maturation, and multi-sensor fusion will accelerate adoption, evolving Ubicept from research spinoff to key enabler in a world where machines must "see" beyond human limits—revolutionizing how they perceive, just as promised.[1][3][4]
Ubicept has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in July 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2023 | $8.0M Seed | Crosslink Capital, E14 Fund, Gaingels, Northpond Ventures, Ubiquity Ventures, Virta Ventures, WestWave Capital, Balaji Srinivasan, Liu Jiang |